Agilent Technologies (NYSE:A – Get Rating) issued an update on its first quarter earnings guidance on Monday morning. The company provided EPS guidance of $1.29-$1.31 for the period, compared to the consensus EPS estimate of $1.31. The company issued revenue guidance of $1.68-$1.70 billion, compared to the consensus revenue estimate of $1.73 billion. Agilent Technologies also updated its FY23 guidance to $5.61-$5.69 EPS.
Agilent Technologies Stock Up 8.1 %
A stock opened at $156.86 on Wednesday. The stock has a market capitalization of $46.44 billion, a P/E ratio of 35.73, a PEG ratio of 2.67 and a beta of 1.06. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.41 and a current ratio of 1.94. Agilent Technologies has a one year low of $112.52 and a one year high of $162.62. The company has a 50 day moving average price of $133.55 and a two-hundred day moving average price of $128.29.
Agilent Technologies (NYSE:A – Get Rating) last announced its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.14. The company had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.76 billion. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. Agilent Technologies’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter last year, the business earned $1.21 EPS. As a group, sell-side analysts expect that Agilent Technologies will post 5.07 EPS for the current year.
Agilent Technologies Increases Dividend
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on A shares. Credit Suisse Group started coverage on Agilent Technologies in a research report on Wednesday, August 24th. They set an outperform rating and a $165.00 price target on the stock. SVB Leerink increased their price target on Agilent Technologies from $145.00 to $160.00 and gave the stock an outperform rating in a research note on Tuesday. KeyCorp increased their price objective on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an overweight rating in a report on Tuesday. Robert W. Baird upped their target price on Agilent Technologies from $160.00 to $170.00 in a research report on Tuesday. Finally, Citigroup upped their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company a neutral rating in a report on Tuesday. Four equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus target price of $157.00.
Insider Buying and Selling
In other Agilent Technologies news, VP Padraig Mcdonnell sold 2,103 shares of the business’s stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the completion of the sale, the vice president now owns 13,217 shares of the company’s stock, valued at $1,624,237.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 6,775 shares of the firm’s stock in a transaction that occurred on Wednesday, November 16th. The stock was sold at an average price of $148.19, for a total value of $1,003,987.25. Following the sale, the chief executive officer now owns 270,896 shares of the company’s stock, valued at approximately $40,144,078.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Padraig Mcdonnell sold 2,103 shares of the stock in a transaction that occurred on Wednesday, September 28th. The shares were sold at an average price of $122.89, for a total value of $258,437.67. Following the completion of the sale, the vice president now directly owns 13,217 shares of the company’s stock, valued at $1,624,237.13. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,309 shares of company stock worth $4,846,147.
Institutional Trading of Agilent Technologies
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Penserra Capital Management LLC bought a new position in Agilent Technologies in the first quarter worth $60,000. Covestor Ltd boosted its stake in Agilent Technologies by 171.0% in the 1st quarter. Covestor Ltd now owns 1,241 shares of the medical research company’s stock valued at $164,000 after buying an additional 783 shares in the last quarter. Brown Brothers Harriman & Co. boosted its stake in shares of Agilent Technologies by 169.5% in the 1st quarter. Brown Brothers Harriman & Co. now owns 1,237 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 778 shares in the last quarter. Geller Advisors LLC lifted its holdings in Agilent Technologies by 18.5% during the 1st quarter. Geller Advisors LLC now owns 1,602 shares of the medical research company’s stock valued at $212,000 after purchasing an additional 250 shares during the last quarter. Finally, Atria Wealth Solutions Inc. bought a new position in shares of Agilent Technologies in the second quarter valued at approximately $219,000.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.